Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia

Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), E. Donnall Thomas(AbbVie (United States)), John A. Hansen(University of Washington), Patricia Stewart(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Keith M. Sullivan(Duke Medical Center), Lawrence G. Lum(University of Virginia), K Doney(University of Washington Medical Center), Frederick R. Appelbaum(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Paul J. Martin(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Vernon T. Farewell(University of Cambridge), John Whitehead(Lancaster University), Jean E. Sanders(Carolinas Medical Center), Reginald A. Clift(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), CD Buckner(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Roger S. Hill(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Gary C. Yee(American Society of Clinical Oncology), Patrick G. Beatty(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), William Bensinger(Swedish Medical Center), H. Joachim Deeg(Fred Hutch Cancer Center), Robert P. Witherspoon(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Robert W. McGuffin(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
New England Journal of Medicine
March 20, 1986
Cited by 1,455


Related Papers